Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Clinical and Genomic Analysis on Long-term Survivors of EGFR Mutation Positive Advanced Non-small-cell Lung Cancer Patients With Gefitinib Treatment in China

NCT02932345 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02932345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02932345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Clinical and Genomic Analysis on Long-term Survivors of EGFR Mutation Positive Advanced Non-small-cell Lung Cancer Patients With Gefitinib Treatment in China
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Terminated
Start date
October 31, 2016
Completion date
July 4, 2017
Enrollment
59 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

egfr mutation positive advanced non-small-cell lung cancer